Non-statin cholesterol drugs on Blue Shield Rx Enhanced (S2468-004)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), California
- Premium
- $227.80/month
- Deductible
- None
4 of 8 Non-statin cholesterol drugs are covered on this plan. 1 of them require prior authorization.
4 aren't on the formulary, including Praluent and Nexletol.
- $7.00Tier 2
- 19%Tier 3
- $7.00Tier 2
- from $36.33Tier 4
Not on the formulary
Praluent, Nexletol, Nexlizet, Vascepa
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.